シンバスタチン薬の世界市場動向・分析2018-2025

QYResearchが発行した調査報告書(QYR8D09518)
◆英語タイトル:Global Simvastatin Drug Industry Research Report, Growth Trends and Competitive Analysis 2018-2025
◆商品コード:QYR8D09518
◆発行会社(リサーチ会社):QYResearch
◆発行日:2018年11月12日
◆ページ数:117
◆レポート形式:英語 / PDF
◆納品方法:Eメール(受注後3営業日)
◆調査対象地域:グローバル、世界主要国
◆産業分野:製薬・ヘルスケア
◆販売価格オプション(消費税別)
Single User(1名様閲覧用)USD4,900 ⇒換算¥651,700見積依頼/購入/質問フォーム
Enterprise(同一法人内共有可)USD9,800 ⇒換算¥1,303,400見積依頼/購入/質問フォーム
販売価格オプションの説明はこちらでご利用ガイドはこちらでご確認いただけます。
※お支払金額は「換算金額(日本円)+消費税+配送料(Eメール納品は無料)」です。
※本体価格が¥30,000未満のレポートにつきましては、ハンドリングチャージ¥5,000が別途かかります。
※Eメールによる納品の場合、通常ご注文当日〜2日以内に納品致します。
※レポート納品後、納品日+5日以内に請求書を発行し、お客様宛に郵送いたしますので、請求書発行日より2ヶ月以内に銀行振込にて支払をお願いします。
※上記の日本語題名はH&Iグローバルリサーチが翻訳したものです。英語版原本には日本語表記はありません。
※為替レートは適宜修正・更新しております。リアルタイム更新ではありません。
※弊社H&Iグローバルリサーチ株式会社はQYResearch社の日本における正規代理店です。同社発行の市場リサーチレポート及びリサーチサービスに関するお問い合わせは弊社までお願い致します。QYResearch社の概要及び新刊レポートはこちらでご確認いただけます。

本調査レポートは、シンバスタチン薬の世界市場について調査・分析し、種類別には、5mg、10mg、20mg、40mg、80mgに、用途別には、大人、子供(10〜17歳)に区分してまとめました。調査対象企業は、Merck、Salerno Pharma、Teva Pharmaceutical、Aurobindo Pharma、Dr. Reddy's Laboratories、Zydus Pharmaceuticals、Biocon、Lupin Pharmaceuticals、Accord Healthcare、Mylan等です。

・レポートの概要
・グローバル成長トレンド
・シンバスタチン薬の世界市場規模
・シンバスタチン薬の地域別市場規模
・グローバル産業動向
・企業別市場シェア
・企業別シンバスタチン薬の価格動向
・シンバスタチン薬の種類別市場規模(5mg、10mg、20mg、40mg、80mg)
・シンバスタチン薬の用途別市場規模(大人、子供(10〜17歳))
・シンバスタチン薬の北米市場(アメリカ、カナダ、メキシコ)
・シンバスタチン薬のヨーロッパ市場(ドイツ、フランス、イギリス、イタリア、ロシア)
・シンバスタチン薬のアジア市場(日本、中国、韓国、インド、オーストラリア、インドネシア、タイ、マレーシア、フィリピン、ベトナム)
・シンバスタチン薬の中南米市場(ブラジル等)
・シンバスタチン薬の中東・アフリカ市場(GCC、エジプト、南アフリカ)
・主要企業情報(Merck、Salerno Pharma、Teva Pharmaceutical、Aurobindo Pharma、Dr. Reddy's Laboratories、Zydus Pharmaceuticals、Biocon、Lupin Pharmaceuticals、Accord Healthcare、Mylan)
 -企業概要、事業概要、販売・売上・市場シェア、XXX製品概要、企業動向
・バリューチェーン及び販売チャネル分析
・シンバスタチン薬の市場規模予測
・シンバスタチン薬の種類別市場予測2018-2025(5mg、10mg、20mg、40mg、80mg)
・シンバスタチン薬の用途別市場予測2018-2025(大人、子供(10〜17歳))
・シンバスタチン薬の北米市場予測2018-2025(アメリカ、カナダ、メキシコ)
・シンバスタチン薬のヨーロッパ市場予測2018-2025(ドイツ、フランス、イギリス、イタリア、ロシア)
・シンバスタチン薬のアジア市場予測2018-2025(日本、中国、韓国、インド、オーストラリア、インドネシア、タイ、マレーシア、フィリピン、ベトナム)
・シンバスタチン薬の中南米市場予測2018-2025(ブラジル等)
・シンバスタチン薬の中東・アフリカ市場予測2018-2025(GCC、エジプト、南アフリカ)
・調査結果及び結論
【レポートの概要】

Simvastatin, marketed under the trade name Zocor among others, is a lipid-lowering medication. It is used along with exercise, diet, and weight loss to decrease elevated lipid (fat) levels. It is also used to decrease the risk of heart problems in those at high risk. It is taken by mouth.In 2018, the global Simvastatin Drug market size was xx million US$ and is forecast to xx million US in 2025, growing at a CAGR of xx% from 2018. In this study, 2017 has been considered as the base year and 2018 to 2025 as the forecast period to estimate the market size for Simvastatin Drug.

This study researches the market size of Simvastatin Drug, presents the global Simvastatin Drug sales and revenue by companies, regions, type and application, history breakdown data from 2013 to 2018, and forecast to 2025.
This report focuses on the key data information of Simvastatin Drug in key regions like North America, Europe, Asia Pacific, Central & South America, and Middle East & Africa, presents sales, revenue, market share, growth rate of Simvastatin Drug for each region and countries in each region.
For top companies, this report investigates and analyzes the sales, revenue, market share and growth rate for the top players, key data from 2013 to 2018.
This report also studies the global market status, competition landscape, market share, growth rate, future trends, market drivers, opportunities and challenges, sales channels, distributors and Porter’s Five Forces Analysis.

This report includes the following manufacturers; we can also add the other companies as you want.
Merck
Salerno Pharma
Teva Pharmaceutical
Aurobindo Pharma
Dr. Reddy’s Laboratories
Zydus Pharmaceuticals
Biocon
Lupin Pharmaceuticals
Accord Healthcare
Mylan

Market Segment by Product Type
5mg
10mg
20mg
40mg
80mg

Market Segment by Application
Adult
Children(10-17 years)

Market size split by Region
North America
United States
Canada
Mexico
Asia-Pacific
China
India
Japan
South Korea
Australia
Indonesia
Malaysia
Philippines
Thailand
Vietnam
Europe
Germany
France
UK
Italy
Russia
Central & South America
Brazil
Rest of Central & South America
Middle East & Africa
GCC Countries
Egypt
South Africa

The study objectives are:
To analyze and research the global Simvastatin Drug status and future forecast, involving capacity, production, value, consumption, growth rate (CAGR), market share, historical and forecast.
To present the key Simvastatin Drug manufacturers, capacity, production, revenue, market share, and recent development for key players.
To split the breakdown data by regions, type, companies and applications.
To analyze the global and key regions market potential and advantage, opportunity and challenge, restraints and risks.
To identify significant trends, drivers, influence factors in global and regions.
To analyze competitive developments such as expansions, agreements, new product launches, and acquisitions in the market.

In this study, the years considered to estimate the market size of Simvastatin Drug are as follows:
History Year: 2013-2018
Base Year: 2017
Estimated Year: 2018
Forecast Year 2018 to 2025

【レポートの目次】

Table of Contents

1 Report Overview
1.1 Research Scope
1.2 Major Manufacturers Covered in This Report
1.3 Market Segment by Type
1.3.1 Global Simvastatin Drug Market Size Growth Rate by Type
1.3.2 5mg
1.3.3 10mg
1.3.4 20mg
1.3.5 40mg
1.3.6 80mg
1.4 Market Segment by Application
1.4.1 Global Simvastatin Drug Market Share by Application (2018-2025)
1.4.2 Adult
1.4.3 Children(10-17 years)
1.5 Study Objectives
1.6 Years Considered

2 Global Growth Trends
2.1 Global Simvastatin Drug Market Size
2.1.1 Global Simvastatin Drug Revenue 2013-2025
2.1.2 Global Simvastatin Drug Sales 2013-2025
2.2 Simvastatin Drug Growth Rate by Regions
2.2.1 Global Simvastatin Drug Sales by Regions 2013-2018
2.2.2 Global Simvastatin Drug Revenue by Regions 2013-2018
2.3 Industry Trends
2.3.1 Market Top Trends
2.3.2 Market Drivers

3 Market Share by Manufacturers
3.1 Simvastatin Drug Sales by Manufacturers
3.1.1 Simvastatin Drug Sales by Manufacturers 2013-2018
3.1.2 Simvastatin Drug Sales Market Share by Manufacturers 2013-2018
3.2 Revenue by Manufacturers
3.2.1 Simvastatin Drug Revenue by Manufacturers (2013-2018)
3.2.2 Simvastatin Drug Revenue Share by Manufacturers (2013-2018)
3.2.3 Global Simvastatin Drug Market Concentration Ratio (CR5 and HHI)
3.3 Simvastatin Drug Price by Manufacturers
3.4 Key Manufacturers Simvastatin Drug Plants/Factories Distribution and Area Served
3.5 Date of Key Manufacturers Enter into Simvastatin Drug Market
3.6 Key Manufacturers Simvastatin Drug Product Offered
3.7 Mergers & Acquisitions, Expansion Plans

4 Market Size by Type
4.1 Sales and Revenue for Each Type
4.1.1 5mg Sales and Revenue (2013-2018)
4.1.2 10mg Sales and Revenue (2013-2018)
4.1.3 20mg Sales and Revenue (2013-2018)
4.1.4 40mg Sales and Revenue (2013-2018)
4.1.5 80mg Sales and Revenue (2013-2018)
4.2 Global Simvastatin Drug Sales Market Share by Type
4.3 Global Simvastatin Drug Revenue Market Share by Type
4.4 Simvastatin Drug Price by Type

5 Market Size by Application
5.1 Overview
5.2 Global Simvastatin Drug Sales by Application

6 North America
6.1 North America Simvastatin Drug Breakdown Data by Company
6.2 North America Simvastatin Drug Breakdown Data by Type
6.3 North America Simvastatin Drug Breakdown Data by Application
6.4 North America Simvastatin Drug Breakdown Data by Countries
6.4.1 North America Simvastatin Drug Sales by Countries
6.4.2 North America Simvastatin Drug Revenue by Countries
6.4.3 United States
6.4.4 Canada
6.4.5 Mexico

7 Europe
7.1 Europe Simvastatin Drug Breakdown Data by Company
7.2 Europe Simvastatin Drug Breakdown Data by Type
7.3 Europe Simvastatin Drug Breakdown Data by Application
7.4 Europe Simvastatin Drug Breakdown Data by Countries
7.4.1 Europe Simvastatin Drug Sales by Countries
7.4.2 Europe Simvastatin Drug Revenue by Countries
7.4.3 Germany
7.4.4 France
7.4.5 UK
7.4.6 Italy
7.4.7 Russia

8 Asia Pacific
8.1 Asia Pacific Simvastatin Drug Breakdown Data by Company
8.2 Asia Pacific Simvastatin Drug Breakdown Data by Type
8.3 Asia Pacific Simvastatin Drug Breakdown Data by Application
8.4 Asia Pacific Simvastatin Drug Breakdown Data by Countries
8.4.1 Asia Pacific Simvastatin Drug Sales by Countries
8.4.2 Asia Pacific Simvastatin Drug Revenue by Countries
8.4.3 China
8.4.4 Japan
8.4.5 Korea
8.4.6 India
8.4.7 Australia
8.4.8 Indonesia
8.4.9 Malaysia
8.4.10 Philippines
8.4.11 Thailand
8.4.12 Vietnam

9 Central & South America
9.1 Central & South America Simvastatin Drug Breakdown Data by Company
9.2 Central & South America Simvastatin Drug Breakdown Data by Type
9.3 Central & South America Simvastatin Drug Breakdown Data by Application
9.4 Central & South America Simvastatin Drug Breakdown Data by Countries
9.4.1 Central & South America Simvastatin Drug Sales by Countries
9.4.2 Central & South America Simvastatin Drug Revenue by Countries
9.4.3 Brazil

10 Middle East and Africa
10.1 Middle East and Africa Simvastatin Drug Breakdown Data by Type
10.2 Middle East and Africa Simvastatin Drug Breakdown Data by Application
10.3 Middle East and Africa Simvastatin Drug Breakdown Data by Countries
10.3.1 Middle East and Africa Simvastatin Drug Sales by Countries
10.3.2 Middle East and Africa Simvastatin Drug Revenue by Countries
10.3.3 GCC Countries
10.3.4 Egypt
10.3.5 South Africa

11 Company Profiles
11.1 Merck
11.1.1 Merck Company Details
11.1.2 Company Description and Business Overview
11.1.3 Sales, Revenue and Market Share of Simvastatin Drug
11.1.4 Simvastatin Drug Product Introduction
11.1.5 Merck Recent Development
11.2 Salerno Pharma
11.2.1 Salerno Pharma Company Details
11.2.2 Company Description and Business Overview
11.2.3 Sales, Revenue and Market Share of Simvastatin Drug
11.2.4 Simvastatin Drug Product Introduction
11.2.5 Salerno Pharma Recent Development
11.3 Teva Pharmaceutical
11.3.1 Teva Pharmaceutical Company Details
11.3.2 Company Description and Business Overview
11.3.3 Sales, Revenue and Market Share of Simvastatin Drug
11.3.4 Simvastatin Drug Product Introduction
11.3.5 Teva Pharmaceutical Recent Development
11.4 Aurobindo Pharma
11.4.1 Aurobindo Pharma Company Details
11.4.2 Company Description and Business Overview
11.4.3 Sales, Revenue and Market Share of Simvastatin Drug
11.4.4 Simvastatin Drug Product Introduction
11.4.5 Aurobindo Pharma Recent Development
11.5 Dr. Reddy’s Laboratories
11.5.1 Dr. Reddy’s Laboratories Company Details
11.5.2 Company Description and Business Overview
11.5.3 Sales, Revenue and Market Share of Simvastatin Drug
11.5.4 Simvastatin Drug Product Introduction
11.5.5 Dr. Reddy’s Laboratories Recent Development
11.6 Zydus Pharmaceuticals
11.6.1 Zydus Pharmaceuticals Company Details
11.6.2 Company Description and Business Overview
11.6.3 Sales, Revenue and Market Share of Simvastatin Drug
11.6.4 Simvastatin Drug Product Introduction
11.6.5 Zydus Pharmaceuticals Recent Development
11.7 Biocon
11.7.1 Biocon Company Details
11.7.2 Company Description and Business Overview
11.7.3 Sales, Revenue and Market Share of Simvastatin Drug
11.7.4 Simvastatin Drug Product Introduction
11.7.5 Biocon Recent Development
11.8 Lupin Pharmaceuticals
11.8.1 Lupin Pharmaceuticals Company Details
11.8.2 Company Description and Business Overview
11.8.3 Sales, Revenue and Market Share of Simvastatin Drug
11.8.4 Simvastatin Drug Product Introduction
11.8.5 Lupin Pharmaceuticals Recent Development
11.9 Accord Healthcare
11.9.1 Accord Healthcare Company Details
11.9.2 Company Description and Business Overview
11.9.3 Sales, Revenue and Market Share of Simvastatin Drug
11.9.4 Simvastatin Drug Product Introduction
11.9.5 Accord Healthcare Recent Development
11.10 Mylan
11.10.1 Mylan Company Details
11.10.2 Company Description and Business Overview
11.10.3 Sales, Revenue and Market Share of Simvastatin Drug
11.10.4 Simvastatin Drug Product Introduction
11.10.5 Mylan Recent Development

12 Value Chain and Sales Channels Analysis
12.1 Value Chain Analysis
12.2 Sales Channels Analysis
12.2.1 Simvastatin Drug Sales Channels
12.2.2 Simvastatin Drug Distributors
12.3 Simvastatin Drug Customers

13 Market Forecast
13.1 Global Simvastatin Drug Sales and Revenue Forecast 2018-2025
13.2 Global Simvastatin Drug Sales Forecast by Type
13.3 Global Simvastatin Drug Sales Forecast by Application
13.4 Simvastatin Drug Forecast by Regions
13.4.1 Global Simvastatin Drug Sales Forecast by Regions 2018-2025
13.4.2 Global Simvastatin Drug Revenue Forecast by Regions 2018-2025
13.5 North America Market Forecast
13.5.1 North America Simvastatin Drug Forecast by Countries 2018-2025
13.5.2 United States
13.5.3 Canada
13.5.4 Mexico
13.6 Europe Market Forecast
13.6.1 Europe Simvastatin Drug Forecast by Countries 2018-2025
13.6.2 Germany
13.6.3 France
13.6.4 UK
13.6.5 Italy
13.6.6 Russia
13.7 Asia Pacific Market Forecast
13.7.1 Asia Pacific Simvastatin Drug Sales Forecast by Countries 2018-2025
13.7.2 China
13.7.3 Japan
13.7.4 Korea
13.7.5 India
13.7.6 Australia
13.7.7 Indonesia
13.7.8 Thailand
13.7.9 Malaysia
13.7.10 Philippines
13.7.11 Vietnam
13.8 Central & South America Market Forecast
13.8.1 Central & South America Simvastatin Drug Sales Forecast by Countries 2018-2025
13.8.2 Brazil
13.9 Middle East and Africa Market Forecast
13.9.1 Middle East and Africa Simvastatin Drug Sales Forecast by Countries 2018-2025
13.9.2 GCC Countries
13.9.3 Egypt
13.9.4 South Africa

14 Research Findings and Conclusion

15 Appendix
15.1 Research Methodology
15.1.1 Methodology/Research Approach
15.1.1.1 Research Programs/Design
15.1.1.2 Market Size Estimation
15.1.1.3 Market Breakdown and Data Triangulation
15.1.2 Data Source
15.1.2.1 Secondary Sources
13.1.2.2 Primary Sources
15.2 Author Details
15.3 Disclaimer

...

【掲載企業】

Merck、Salerno Pharma、Teva Pharmaceutical、Aurobindo Pharma、Dr. Reddy's Laboratories、Zydus Pharmaceuticals、Biocon、Lupin Pharmaceuticals、Accord Healthcare、Mylan

【免責事項】
https://www.globalresearch.jp/disclaimer

★リサーチレポート[ シンバスタチン薬の世界市場動向・分析2018-2025(Global Simvastatin Drug Industry Research Report, Growth Trends and Competitive Analysis 2018-2025)]についてメールでお問い合わせはこちらでお願いします。